Akorn Enters Into A Commercial Manufacturing Supply Agreement For Three OTC Products

Akorn, Inc. recently announced the signing of a five-year commercial manufacturing and supply agreement with a U.S. ophthalmic company. Under the terms of the five-year agreement, Akorn will be responsible for the exclusive manufacturing and supply of three OTC eye care products. The line of products will be manufactured at Akorn's Decatur, IL production facility and are targeted for distribution in the U.S. and world wide markets.

Arthur S. Przybyl, Akorn's President and Chief Executive Officer stated, "This partnership reflects Akorn's strong commitment to bringing high quality contract manufacturing services to the ophthalmic industry. We look forward to working closely with our partner to commercialize their OTC line of products."

About Akorn, Inc.
Akorn, Inc. manufactures and markets sterile specialty pharmaceuticals. Akorn has manufacturing facilities located in Decatur, Illinois and Somerset, New Jersey and markets and distributes an extensive line of hospital and ophthalmic pharmaceuticals. Additional information is available at the Company's website at www.akorn.com.

SOURCE: Akorn, Inc.